Anesthesia And Respiratory Devices Market (By Product: Respiratory Devices, Anesthesia Devices)- Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The global anesthesia And respiratory devices market was valued at USD 47.94 billion in 2021 and it is predicted to surpass around USD 76.25 billion by 2030 with a CAGR of 5.29% from 2022 to 2030

Anesthesia And Respiratory Devices Market Size 2021 to 2030

Report Highlights

  • In 2021, the respiratory devices product type segment accounted for the largest share of over 69.06% of the global revenue. 
  • The anesthesia delivery machines segment is anticipated to grow at the fastest growth rate during the forecast period.
  • North America accounted for the largest share of more than 25.74% of the global revenue in 2021. 
  • The Asia Pacific region is expected to witness the fastest CAGR from 2022 to 2030.

Increasing prevalence of respiratory diseases, patient preferences for a reduced hospital stay and supportive government funding are among the key driving factors. Furthermore, aging is considered one of the greatest risk factors for the development of sleep apnea disorders and is, therefore, expected to be a high-impact rendering driver for this industry. The COVID-19 pandemic had a significant impact on the industry. Different segments were impacted differently. For instance, the ventilators segment witnessed exponential growth owing to the sudden surge in the demand for mechanical ventilators.

However, this demand decreased post-2021, wherein the industry size decreased dramatically. Concerning the nebulizers segment, people were apprehensive to use nebulizers owing to the use of inhaled medications, which are considered a potential source of viral transmission and immunosuppression, which restricted the growth, but did not negatively impact the industry. Shifting the preference of patients towards reduced hospital stay is anticipated to increase the adoption of anesthesia and breathing instruments, thereby, driving the market. As per the American Hospital Association, approximately 20% of Medicare beneficiaries, when discharged from the hospital return within 30 days. Identifying and reducing avoidable readmissions is expected to improve healthcare safety and reduce spending.

Hence, policymakers are striving to reduce the hospital stays of patients. In the Patient Protection and Affordable Act, Congress initiated the Hospital Readmission Reduction Program (HRRP), under which, Medicare is allowed to penalize hospitals for higher rates of readmissions since 2013. Due to the implementation of this act, many physicians and patients opt for anesthesia and breathing devices, such as ambulatory infusion pumps and home respiratory monitors. Key players are taking initiatives to develop advanced instruments to bring improvement in the treatment. For instance, in May 2022, Max Ventilator launched Non-Invasive (NIV) ventilators consisting of inbuilt humidifiers and oxygen therapy. The device is user-friendly as well as lightweight and is also priced lower than the traditional ventilators. Such initiatives are anticipated to propel industry growth in the coming years.

Scope of The Report

Report Coverage Details
Market Size in 2021 USD 47.94 billion
Revenue Forecast by 2030 USD 76.25 billion
Growth rate from 2022 to 2030 CAGR of 5.29%
Base Year 2021
Forecast Period 2022 to 2030
Segmentation Product, region
Companies Covered General Electric company; Medtronic; Teleflex Inc.; Koninklijke Philips N.V.; Drägerwerk AG & Co. KGaA; Getinge AB; Smiths Group plc; Fisher & Paykel Healthcare Ltd.; Masimo; B. Braun Melsungen AG; ResMed; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

 

Product Type Insights

In 2021, the respiratory devices product type segment accounted for the largest share of over 69.06% of the global revenue. The increasing prevalence of respiratory diseases, availability of advanced respiratory devices, an increasing number of surgeries performed, and rising healthcare expenditure are the key factors expected to fuel the segment growth over the years to come. Medical equipment termed a respiratory device is used to help a patient with breathing difficulties. These devices are employed in managing and treating conditions including fibrosis, asthma, COPD, and acute respiratory distress syndrome. The anesthesia devices segment is further segmented into anesthesia machines and anesthesia disposables.

The anesthesia machines segment is further divided into anesthesia workstations, anesthesia delivery machines, anesthesia ventilators, and anesthesia monitors. The anesthesia delivery machines segment is anticipated to grow at the fastest growth rate during the forecast period owing to the rising number of surgeries performed and various technological advancements by key players. The respiratory devices segment is further divided into respiratory equipment, respiratory disposables, and respiratory measurement devices. The respiratory equipment segment held the largest revenue share in 2021 and is further sub-segmented into humidifiers, nebulizers, oxygen concentrators, positive airway pressure devices, reusable resuscitators, ventilators, and respiratory inhalers.

Oxygen concentrators were the largest segment in 2021 owing to a surge in their demand, especially during the pandemic. This is because the patients who did not require ventilators were treated using medical oxygen concentrators. Over the projection period, it is anticipated that the high prevalence of COPD and OSA will drive the respiratory devices segment worldwide. For instance, the Global Initiative for Chronic Obstruction Disease's 2018 study estimates that COPD would cause 4.5 million yearly deaths worldwide by 2030. Increased preterm birth rates are also anticipated to support industry expansion. For instance, according to the CDC data published in the year 2020, preterm birth in the United States affected 1 of every 10 infants.

Regional Insights

North America accounted for the largest share of more than 25.74% of the global revenue in 2021. The rise in the geriatric population in the U.S. is leading to a corresponding rise in the volume of surgeries in the country, which further boosts industry growth. For instance, according to the U.S. Census Bureau, more than 54 million adults aged 65 years and above were reported in the U.S. in 2021. In addition, according to the World Health Organization, the percentage of the geriatric population is expected to reach 22% in 2050 from 12% in 2015. In addition, healthcare cost containment issues post the economic crisis have compelled the government to introduce new strategies to reduce the patient stay in hospitals and impose an excise tax on medical devices.

These initiatives have compelled patients and physicians to opt for respiratory and anesthesia monitoring and therapeutic devices for home care. However, the excise tax is expected to negatively affect the Original Equipment Manufacturers (OEMs). The Asia Pacific region is expected to witness the fastest CAGR from 2022 to 2030 owing to the growing elderly population. India’s elderly population (aged 60 years and above) is projected to reach 194 million in 2031 from 138 million in 2021, accounting for a 41% increase over a decade, according to the National Statistical Office Elderly in India 2021 report.

Key Players

  • General Electric Company
  • Medtronic
  • Teleflex Inc.
  • Koninklijke Philips N.V.
  • Drägerwerk AG & Co. KGaA
  • Getinge AB.
  • Smiths Group plc
  • Fisher & Paykel Healthcare Ltd.
  • Masimo
  • B. Braun Melsungen AG
  • ResMed
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Market Segmentation

  • By Product Outlook
    • Respiratory Devices
      • Respiratory Equipment
        • Humidifiers
          • Heat Humidifiers
          • Heated Wire Breathing Circuits
          • Heat Exchangers
          • Pass Over Humidifiers
        • Nebulizers
          • Pneumatic Nebulizers
          • Mesh Nebulizers
          • Ultrasonic Nebulizers
        • Oxygen Concentrator
          • Fixed Oxygen Concentrators
          • Portable Oxygen Concentrators
        • Positive Airway Pressure Devices
          • Bilevel & automatic positive airway pressure devices
          • Continuous positive airway pressure devices
        • Reusable Resuscitators
        • Ventilators
          • Adult Ventilators
          • Neonatal Ventilators
        • Respiratory Inhalers
          • Dry Powdered Inhalers
          • Metered Dose Inhaler
      • Respiratory Disposables
        • Disposable Oxygen Masks
        • Resuscitators
        • Tracheostomy Tubes
        • Oxygen Cannula
      • Respiratory Measurement Devices
        • Pulse Oximetry systems
        • Capnographs
        • Spirometers
        • Peak Flowmeters
    • Anesthesia Devices
      • Anesthesia Machines
        • Anesthesia Workstation
        • Anesthesia delivery machines
          • Portable
          • Standalone
        • Anesthesia Ventilators
        • Anesthesia Monitors
      • Anesthesia Disposables
        • Anesthesia Masks
        • Anesthesia Accessories
  • By Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Thailand
    • Latin America
      • Brazil
      • Mexico
      • Argentina
    • MEA
      • South Africa
      • Saudi Arabia
      • UAE

Chapter 1. Introduction

1.1.Research Objective

1.2.Scope of the Study

1.3.Definition

Chapter 2. Research Methodology

2.1.Research Approach

2.2.Data Sources

2.3.Assumptions & Limitations

Chapter 3. Executive Summary

3.1.Market Snapshot

Chapter 4. Market Variables and Scope

4.1.Introduction

4.2.Market Classification and Scope

4.3.Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5.COVID 19 Impact on Anesthesia And Respiratory Devices Market

5.1. COVID-19 Landscape: Anesthesia And Respiratory Devices Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4.Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1.Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2.Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1.List of Suppliers

7.1.3.2.List of Buyers

Chapter 8. Global Anesthesia And Respiratory Devices Market, By Product

8.1.Anesthesia And Respiratory Devices Market, by Product Type, 2020-2027

8.1.1. Respiratory Devices

8.1.1.1.Market Revenue and Forecast (2016-2027)

8.1.2. Anesthesia Devices

8.1.2.1.Market Revenue and Forecast (2016-2027)

Chapter 9. Global Anesthesia And Respiratory Devices Market, Regional Estimates and Trend Forecast

9.1.North America

9.1.1. Market Revenue and Forecast, by Product (2016-2027)

9.1.2. U.S.

9.1.3. Rest of North America

9.1.3.1.Market Revenue and Forecast, by Product (2016-2027)

9.2.Europe

9.2.1. Market Revenue and Forecast, by Product (2016-2027)

9.2.2. UK

9.2.2.1.Market Revenue and Forecast, by Product (2016-2027)

9.2.3. France

9.2.3.1.Market Revenue and Forecast, by Product (2016-2027)

9.2.4. Rest of Europe

9.2.4.1.Market Revenue and Forecast, by Product (2016-2027)

9.3.APAC

9.3.1. Market Revenue and Forecast, by Product (2016-2027)

9.3.2. India

9.3.2.1.Market Revenue and Forecast, by Product (2016-2027)

9.3.3. China

9.3.3.1.Market Revenue and Forecast, by Product (2016-2027)

9.3.4. Japan

9.3.4.1.Market Revenue and Forecast, by Product (2016-2027)

9.3.5. Rest of APAC

9.3.5.1.Market Revenue and Forecast, by Product (2016-2027)

9.4.MEA

9.4.1. Market Revenue and Forecast, by Product (2016-2027)

9.4.2. GCC

9.4.2.1.Market Revenue and Forecast, by Product (2016-2027)

9.4.3. North Africa

9.4.3.1.Market Revenue and Forecast, by Product (2016-2027)

9.4.4. South Africa

9.4.4.1.Market Revenue and Forecast, by Product (2016-2027)

9.4.5. Rest of MEA

9.4.5.1.Market Revenue and Forecast, by Product (2016-2027)

9.5.Latin America

9.5.1. Market Revenue and Forecast, by Product (2016-2027)

9.5.2. Brazil

9.5.2.1.Market Revenue and Forecast, by Product (2016-2027)

9.5.3. Rest of LATAM

9.5.3.1.Market Revenue and Forecast, by Product (2016-2027)

Chapter 10.Company Profiles

10.1.General Electric Company

10.1.1.Company Overview

10.1.2.Product Offerings

10.1.3.Financial Performance

10.1.4.Recent Initiatives

10.2.Medtronic

10.2.1.Company Overview

10.2.2.Product Offerings

10.2.3.Financial Performance

10.2.4.Recent Initiatives

10.3.Teleflex Inc.

10.3.1.Company Overview

10.3.2.Product Offerings

10.3.3.Financial Performance

10.3.4.Recent Initiatives

10.4.Koninklijke Philips N.V.

10.4.1.Company Overview

10.4.2.Product Offerings

10.4.3.Financial Performance

10.4.4.Recent Initiatives

10.5.Drägerwerk AG & Co. KGaA

10.5.1.Company Overview

10.5.2.Product Offerings

10.5.3.Financial Performance

10.5.4.Recent Initiatives

10.6.Getinge AB.

10.6.1.Company Overview

10.6.2.Product Offerings

10.6.3.Financial Performance

10.6.4.Recent Initiatives

10.7.Smiths Group plc

10.7.1.Company Overview

10.7.2.Product Offerings

10.7.3.Financial Performance

10.7.4.Recent Initiatives

10.8.Fisher & Paykel Healthcare Ltd.

10.8.1.Company Overview

10.8.2.Product Offerings

10.8.3.Financial Performance

10.8.4.Recent Initiatives

10.9.Masimo

10.9.1.Company Overview

10.9.2.Product Offerings

10.9.3.Financial Performance

10.9.4.Recent Initiatives

10.10.B. Braun Melsungen AG

10.10.1. Company Overview

10.10.2. Product Offerings

10.10.3. Financial Performance

10.10.4. Recent Initiatives

Chapter 11.Research Methodology

11.1.Primary Research

11.2.Secondary Research

11.3.Assumptions

Chapter 12.Appendix

12.1.About Us

12.2.Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers